Ciphergen Acquires Invitrogen s Chromatography Business for $12M in Cash | GenomeWeb

NEW YORK, June 25 - Ciphergen Biosystems has agreed to acquire BioSepra, a French chromatography equipment business, from Invitrogen for $12 million in cash, the companies said Monday.

Ciphergen said the acquisition would position it to develop protein purification products for the benchtop biology equipment market and provide additional capabilities for its ProteinChip protein screening and identification platform.  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.